Literature DB >> 11186999

Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging.

J Schulz-Menger1, O Strohm, R Dietz, M G Friedrich.   

Abstract

Contrast-enhanced MRI may serve as a sensitive noninvasive tool for the detection and follow-up of myocardial involvement in patients with systemic sarcoidosis.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11186999     DOI： 10.1007/bf02678505

Source DB:  PubMed          Journal:  MAGMA        ISSN： 0968-5243            Impact factor:   2.310


  4 in total

Review 1.  Cardiovascular magnetic resonance and the evaluation of heart failure.

Authors:  James C C Moon; Sanjay K Prasad
Journal:  Curr Cardiol Rep       Date:  2005-01       Impact factor: 2.931

2.  Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance.

Authors:  J Schulz-Menger; R Wassmuth; H Abdel-Aty; I Siegel; A Franke; R Dietz; M G Friedrich
Journal:  Heart       Date:  2006-03       Impact factor: 5.994

3.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

4.  Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.

Authors:  Edyta Blaszczyk; Ulrike Grieben; Florian von Knobelsdorff-Brenkenhoff; Peter Kellman; Luisa Schmacht; Stephanie Funk; Simone Spuler; Jeanette Schulz-Menger
Journal:  J Cardiovasc Magn Reson       Date:  2019-04-29       Impact factor: 5.364
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.